FDA Inspection 1168200 — The Mount Sinai Hospital

The Mount Sinai Hospital — FEI 2470025

The FDA completed an inspection of The Mount Sinai Hospital on Apr 13, 2022 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 13, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.